Skin Diseases, Viral: Clinical Trials

457 trials for Skin Diseases, Viral, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

318 completed, 54 unknown, 27 recruiting, 20 terminated. 120 Phase 2, 112 Phase 3, 83 Not applicable, 65 Phase 1, 29 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2120Completed 85, Terminated 8, Unknown 8, Withdrawn 6, Not yet recruiting 5, Recruiting 4, Active not recruiting 2, Enrolling by invitation 1, Suspended 1
Phase 3112Completed 78, Unknown 16, Active not recruiting 7, Recruiting 5, Terminated 3, Withdrawn 2, Not yet recruiting 1
Not applicable83Completed 51, Unknown 18, Recruiting 6, Terminated 5, Not yet recruiting 3
Phase 165Completed 54, Terminated 3, Unknown 3, Withdrawn 3, Enrolling by invitation 2
Phase 429Completed 20, Recruiting 5, Terminated 2, Unknown 2
Early Phase 15Withdrawn 2, Completed 1, Not yet recruiting 1, Unknown 1

Follow Skin Diseases, Viral: new trials by email Literature Review of Skin Diseases, Viral trials Research Report on Skin Diseases, Viral

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart
Phase 2SuspendedG&E Herbal Biotechnology Co., LTD1022030-09-012023-09-14
Efficacy and Safety of Oral Ivermectin for Genital Warts
Ivermectin - Genital Warts
Not applicableNot yet recruitingUniversity of Health Sciences Lahore902027-02-202026-11-03
Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM
Busulfan, Palifermin, Plerixafor - WHIM, Warts
Phase 1 / Phase 2Enrolling by invitationNational Institute of Allergy and Infectious Diseases (NIAID)102026-10-212026-10-27
Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts
Intralesional Acyclovir, Intralesional Zinc Sulphate - Warts, Plantar Warts
Phase 3Not yet recruitingAssiut University762026-10-012026-09-29
Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)
VP-102 - Common Warts, Common Warts (Verruca Vulgaris)
Phase 2Not yet recruitingVerrica Pharmaceuticals Inc.302026-10-012026-10-20
Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Geniwa gel, Placebo gel - HPV (Human Papillomavirus)-Associated, Genital Warts
Phase 2RecruitingKTH Biopharma702026-07-162026-10-20
Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases
Acyclovir (ACV), Placebo - Autoimmune Rheumatic Diseases, Recurrent Herpes Simplex
Phase 4RecruitingUniversity of Sao Paulo General Hospital622026-06-252026-08-05
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
VP-102 (US) / TO-208 (Japan), Vehicle (US) / Vehicle (Japan) - Common Warts, Common Warts (Verruca Vulgaris)
Phase 3RecruitingVerrica Pharmaceuticals Inc.3002026-06-152026-09-03
A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)
Recombinant Herpes Zoster Vaccine, adjuvant placebo, Placebo - Herpes
Phase 1Enrolling by invitationChangchun BCHT Biotechnology Co.1202026-05-282026-06-08
Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts
3% hydrogen peroxide solution, 0.9 % saline, Hyperthermia at 44℃ - Warts
Not applicableRecruitingFirst Hospital of China Medical University2102026-05-012026-04-16
A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
HZ Vaccine (IN001), Shingrix - Herpes Zoster
Phase 2Not yet recruitingShenzhen Shenxin Biotechnology Co., Ltd4802026-05-012025-10-07
New Treatment of Common Wart
PRF group, Vitamin D - Common Warts (Verruca Vulgaris)
Not applicableNot yet recruitingSohag University702026-04-062026-04-22
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Cantharidin - Common Warts (Verruca Vulgaris), Common Warts
Phase 3RecruitingVerrica Pharmaceuticals Inc.2502026-03-112026-10-22
Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir
Intralesional Acyclovir, Intralesional Vitamin D3 - Viral Wart, Plantar Wart
Phase 4RecruitingRiphah International University402026-02-202026-08-07
the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.
Ivermectin, microneedling, Salicylic Acid - Warts
Early Phase 1Not yet recruitingAssiut University882026-02-012026-02-09
Evaluating Benzoyl Peroxide for Preventing Recurrence of HSV-1 Outbreaks With Rescue Crossover Option
Benzoyl Peroxide 10% Bar, Placebo - HSV
Phase 2Not yet recruitingGreg Bew1002026-01-012025-08-05
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
VP-102, Vehicle - Common Warts, Common Warts (Verruca Vulgaris)
Phase 3Active not recruitingVerrica Pharmaceuticals Inc.3022025-12-172026-10-23
Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
An infrared hyperthermia device, Hydrogen Peroxide 3 % Topical Solution, Normal Saline (NS) - Refactory Warts
Not applicableRecruitingFirst Hospital of China Medical University802025-10-012026-05-04
Comparison of Efficacy of Topical Adaplene Gel Versus Crythotherapy in Recurrent Plantar Warts
Topical Adapalene Gel 0.1%, Topical Liquid Nitrogen application - Viral Warts
Phase 4RecruitingKhyber Teaching Hospital982025-09-152026-04-29
Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts
9-valent human papillomavirus vaccine, Sterile Saline - Warts, Verruca (Warts)
Phase 2Active not recruitingRush University Medical Center552025-09-022026-09-15

Showing 20 of 457. Sign in to see all of them.

Narrower conditions

Herpes Simplex (159)  ·  Warts (121)  ·  Condylomata Acuminata (113)  ·  Herpes Labialis (52)  ·  Uterine Cervical Neoplasms (45)  ·  Papillomavirus Infections (41)  ·  HIV Infections (29)  ·  Molluscum Contagiosum (22)  ·  Virus Diseases (22)  ·  Herpes Genitalis (19)  ·  Vaginal Neoplasms (18)  ·  Vulvar Neoplasms (18)  ·  Acquired Immunodeficiency Syndrome (16)  ·  Herpesviridae Infections (12)  ·  Skin Diseases (12)

Broader conditions

Skin and Connective Tissue Diseases (457)  ·  DNA Virus Infections (450)  ·  Skin Diseases, Infectious (450)  ·  Infections (448)  ·  Skin Diseases (445)  ·  Virus Diseases (435)  ·  Tumor Virus Infections (230)  ·  Herpesviridae Infections (197)  ·  Papillomavirus Infections (188)  ·  Urogenital Diseases (169)  ·  Genital Diseases (165)  ·  Communicable Diseases (163)  ·  Sexually Transmitted Diseases, Viral (159)  ·  Sexually Transmitted Diseases (153)

Interventions

Acyclovir (31)  ·  Valacyclovir (26)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (16)  ·  Cryotherapy (14)  ·  Vaccines, Synthetic (10)  ·  Famciclovir (9)  ·  ASP2151 (7)  ·  Cantharidin (7)  ·  Papillomavirus Vaccines (7)  ·  VP-102 (7)  ·  Cidofovir (6)  ·  Imiquimod (6)  ·  resiquimod (6)  ·  Foscarnet (5)  ·  PRA1 protein, Candida albicans (5)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (30)  ·  Merck Sharp & Dohme LLC (20)  ·  GlaxoSmithKline (19)  ·  Assiut University (12)  ·  Shanghai Bovax Biotechnology Co., Ltd. (12)  ·  Verrica Pharmaceuticals Inc. (9)  ·  Graceway Pharmaceuticals, LLC (8)  ·  University of Washington (7)  ·  Xiamen University (7)  ·  Aclaris Therapeutics, Inc. (6)  ·  Genocea Biosciences, Inc. (6)  ·  Maruho Europe Limited (5)  ·  Novan, Inc. (5)  ·  Sohag University (5)  ·  Zagazig University (5)

Countries

United States (199)  ·  China (40)  ·  Canada (22)  ·  Egypt (18)  ·  Germany (18)  ·  United Kingdom (17)  ·  France (13)  ·  Australia (11)  ·  Belgium (11)  ·  Pakistan (10)  ·  Japan (9)  ·  Denmark (7)  ·  Spain (7)  ·  Argentina (6)  ·  South Africa (6)

Top investigators

Jun Zhang, Master (5)  ·  Connie Celum, MD, MPH (4)  ·  Jun Zhang, master (4)  ·  Anna Wald, MD, MPH (3)  ·  Shichao Lu, MD (3)  ·  Yongjiang Liu, Bachelor (3)  ·  Christopher M Hull, MD (2)  ·  David H McDermott, M.D. (2)  ·  David W Kimberlin, MD (2)  ·  David W. Kimberlin (2)

Results publications

PMID 32184277, PMID 41276263, PMID 19236277, PMID 19236279, PMID 19935017, PMID 27422279, PMID 30982556, PMID 41166720, PMID 15897380, PMID 20949623, PMID 21471141, PMID 21991950, PMID 22454089, PMID 23066159, PMID 23299013, PMID 23336207, PMID 23632723, PMID 25273231, PMID 26343451, PMID 29074187, PMID 29211620, PMID 29214505, PMID 29995724, PMID 32965495, PMID 33326342, PMID 33599960, PMID 34909721, PMID 34976290, PMID 35142535, PMID 10693114, PMID 10782451, PMID 11238198, PMID 12807939, PMID 13519856, PMID 15168956, PMID 15215482, PMID 15987315, PMID 16973081, PMID 17210977, PMID 17372095, PMID 18008230, PMID 18032894, PMID 18042215, PMID 18082566, PMID 18164106, PMID 18419342, PMID 18433504, PMID 18515521, PMID 18667923, PMID 18846389

NIH funding

N01AI30025 (3), 2004 (2), P01AI030731 (2), 2014 (1), 2016 (1), 2017 (1), P30CA012197 (1), R03HD057773 (1), R21EY036563 (1), U01AI052054 (1), U19AI096398 (1), U54AI150225 (1), UM1CA081457 (1)